Infimab 100 mg

Infimab 100 mg is a prescription biologic medicine containing Infliximab 100 mg. It is supplied as a lyophilized powder concentrate for solution for infusion and is used under specialist supervision for certain inflammatory and autoimmune conditions. Tiny vial, massive immune-system negotiation.

Infliximab is a TNF-alpha blocker / monoclonal antibody used for conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis, depending on the doctor’s diagnosis and treatment plan.

Composition:

Infliximab – 100 mg/vial
r-DNA Origin

Key Information:

Brand Name: Infimab
Strength: 100 mg
Active Ingredient: Infliximab
Dosage Form: Lyophilized powder for concentrate for solution for infusion
Medicine Type: Biologic medicine / Monoclonal antibody / TNF-alpha inhibitor
Manufacturer/Brand Shown: To be verified from physical label
Common Use: Treatment of selected autoimmune and inflammatory disorders
Administration: Intravenous infusion only
Category: Prescription medicine
Pack Size: 1 vial

How It Works:

Infimab 100 mg works by blocking tumor necrosis factor-alpha, also called TNF-alpha, a substance in the body that can cause inflammation. By reducing TNF-alpha activity, infliximab may help control inflammation in conditions affecting the joints, gut, skin, and spine. Because apparently the immune system sometimes needs a strongly worded memo.

Potential Indications:

• Rheumatoid arthritis
• Crohn’s disease
• Ulcerative colitis
• Ankylosing spondylitis
• Psoriatic arthritis
• Plaque psoriasis
• Other specialist-directed use based on diagnosis and reports

Dosage & Storage:

Use only as directed by a qualified healthcare professional.
This medicine should be reconstituted, diluted, and administered only by trained medical staff.
Do not self-administer.
Infliximab is given by intravenous infusion, and dosing depends on the condition being treated, body weight, response, and doctor’s treatment schedule. Official product information notes that infliximab infusion is usually given over a monitored period, and patients are observed during and after infusion.
Store as per the product label and hospital pharmacy instructions.
Keep out of reach of children.

Important Safety Information:

Infliximab should be used only under medical supervision, especially in patients with infection risk, tuberculosis history, hepatitis B, heart failure, nervous system disorders, cancer history, or previous allergic/infusion reactions.

Possible side effects may include:

• Headache
• Fever or chills
• Nausea
• Abdominal pain
• Rash or itching
• Cough or throat irritation
• Infusion reaction
• Increased risk of infections
• Low blood pressure during infusion
• Joint or muscle pain

Serious risks may include severe infections, tuberculosis reactivation, hepatitis B reactivation, serious allergic reactions, heart failure worsening, and rare malignancy-related risks. Report symptoms like fever, persistent cough, weight loss, night sweats, breathing difficulty, chest pain, severe rash, yellowing of skin/eyes, or unusual weakness to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, reconstitution instructions, dosage directions, and route of administration.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.